Artax Biopharma
PrivateLast Round
Early Stage
VC
May 5, 2026
Total Funding Raised
$44M
Momentum Score
25 /100
Company Overview
Artax Biopharma is a biopharmaceutical company that develops small molecule drugs designed to treat autoimmune and inflammatory diseases by targeting harmful pathogens while preserving the body's own tissues, allowing for effective treatment with reduced side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Artax Biopharma Comps
Public and private peers based on sector, stage, and business model.
Artax Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | May 5, 2026 | ||||
| Convertible Debt | Aug 6, 2024 | ||||
| Series C | May 11, 2022 | ||||
| Series B Extension | Jun 4, 2020 | ||||
| Series B | Sep 22, 2015 |
Key People
Founding team and executive leadership
Artax Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Columbus Ventures | Convertible Debt |
| Advent Life Sciences | Convertible Debt, Series C, Series B |
| Columbus Venture Partners | Convertible Debt, Series C, Series B Extension |
| Sound Bioventures | Convertible Debt, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
$19M raised in early stage VC round.
- Mar 7, 2025
Presented preclinical data at the 2025 American Academy of Dermatology Annual Meeting.
Artax Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Artax Biopharma's valuation, stock price, and market status.
